ArticleJournal of the National Cancer Institute2022

RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients.

Natalie Klar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.